Mechanism of extracellular release of human neutrophil calprotectin complex

…, A Panyutich, KT Miyasaki, RK Murthy - Journal of leukocyte …, 2001 - academic.oup.com
Calprotectin is an abundant cytosolic protein complex of humanneutrophils with in vitro
extracellular antimicrobial activity. Studiessuggest that calprotectin may be actively secreted from …

Healthcare personnel attire in non-operating-room settings

…, J Mayer, LS Munoz-Price, R Murthy… - Infection Control & …, 2014 - cambridge.org
Healthcare personnel (HCP) attire is an aspect of the medical profession steeped in culture
and tradition. The role of attire in cross-transmission remains poorly established, and until …

Animals in healthcare facilities: recommendations to minimize potential risks

R Murthy, G Bearman, S Brown, K Bryant… - infection control & …, 2015 - cambridge.org
PURPOSE Animals may be present in healthcare facilities for multiple reasons. Although
specific laws regarding the use of service animals in public facilities were established in the …

Infection prevention in the operating room anesthesia work area

…, G Holzmann-Pazgal, R Murthy… - Infection Control & …, 2019 - cambridge.org
Purpose The potential for clinically significant microbial cross transmission in the intraoperative
environment poses a threat to patient safety. A growing body of literature has shown …

First 12 patients with coronavirus disease 2019 (COVID-19) in the United States

…, S Moon, M Morgan, RN Moro, J Murray, R Murthy… - MedRxiv, 2020 - medrxiv.org
Introduction More than 93,000 cases of coronavirus disease (COVID-19) have been reported
worldwide. We describe the epidemiology, clinical course, and virologic characteristics of …

Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus

DJ Morgan, R Murthy, LS Munoz-Price… - infection control & …, 2015 - cambridge.org
BACKGROUNDWhether contact precautions (CP) are required to control the endemic
transmission of methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant …

Duration of contact precautions for acute-care settings

…, S Leekha, DJ Morgan, R Murthy… - infection control & …, 2018 - cambridge.org
PURPOSE This expert guidance document (EG) provides recommendations regarding
discontinuation of contact precautions (CP) at the individual patient level in acute-care hospitals …

Antibiotics for treatment of Clostridium difficile infection in hospitalized patients with inflammatory bowel disease

…, EA Vasiliauskas, J Grein, R Murthy… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Patients with inflammatory bowel disease (IBD), namely ulcerative colitis (UC) and Crohn's
disease (CD), have worse outcomes with Clostridium difficile infection (CDI), including …

Implementation of strategies to control antimicrobial resistance

R Murthy - Chest, 2001 - Elsevier
Antimicrobial resistance has emerged as a major public health issue in recent years. A steady
increase in resistance continues despite the introduction of new antibiotics, and resistant …

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes

DI Hsu, MP Okamoto, R Murthy… - Journal of …, 2005 - academic.oup.com
Objectives: Resistance among Pseudomonas aeruginosa has risen dramatically and
parallels the increase in fluoroquinolone (FQ) prescribing in recent years. Risk factors for FQ …